Marleen Johanna Limbourg
Director/Board Member at THERAtRAME SA
Profile
Marleen Johanna Limbourg is the founder of Sneezz BVBA, which was founded in 2017.
She held the position of Chief Marketing Officer from 2017 to 2021.
Currently, she holds multiple positions, including Director at Bingli NV and THERAtRAME SA, Board Member at Vlaams Instituut voor Biotechnologie - Flanders Institute, and Investment Manager at Noshaq SA. Dr. Limbourg has previously worked as Director Medical & Scientific Affairs at TiGenix NV from 2011 to 2014 and as Director Global Medical Affairs at UCB SA from 2005 to 2010.
She holds a doctorate degree from Katholieke Universiteit Leuven, which was conferred in 1997, and an MBA from Vlerick Leuven Gent Management School, which was conferred in 2005.
Marleen Johanna Limbourg active positions
| Companies | Position | Start |
|---|---|---|
Noshaq SA
 Noshaq SA Investment ManagersFinance Noshaq SA is an independent private equity/venture capital firm founded in 1985. Noshaq SA is headquartered in Liege. | Private Equity Investor | 2021-12-31 |
Bingli NV
 Bingli NV Data Processing ServicesTechnology Services Bingli NV is a Belgian healthcare company that aims to free up 30%% of a doctor's time by reducing administrative burden and providing high-quality information for the right care at the right time. The company's mission is to put empathy back in healthcare by asking smart medical questions in advance, allowing doctors to be better prepared and appointments to be more time-efficient. The company is based in Antwerp, Belgium and was founded by Tom Van de Putte, Erica Cornu, Piet Van de Steen. Bingli's algorithms are used by more than 400,000 patients. | Director/Board Member | 2022-02-26 |
THERAtRAME SA
 THERAtRAME SA BiotechnologyHealth Technology THERAtRAME SA is a drug discovery start-up company based in Liege, Belgium. The Belgian company aims to become a leader in the development and positioning of novel cancer therapies by exploring new target areas to develop innovative cancer therapies. THERAtRAME's discovery platform integrates unique sets of technologies to discover, develop, and position new drugs to beat reluctant cancers. The company exploits the latest scientific discoveries highlighting the unexpected importance of trna epitranscriptomics dynamics in cancer. THERAtRAME is looking for a drug discovery assay developer leader to join their team. The company was founded by Francesca Rapino, Pierre Close, and has a team of experienced professionals with backgrounds in life sciences, medico-marketing, and biotech venture creations. | Director/Board Member | 2022-07-31 |
Vlaams Instituut voor Biotechnologie - Flanders Institute
 Vlaams Instituut voor Biotechnologie - Flanders Institute Other Consumer ServicesConsumer Services Vlaams Instituut voor Biotechnologie - Flanders Institute operates as a non-profit organization, provides research and development services. It specializes in translating basic scientific results into pharmaceutical, agricultural and industrial applications. The company was founded on January 1, 1996 and is headquartered in Ghent, Belgium. | Director/Board Member | 2018-01-31 |
Former positions of Marleen Johanna Limbourg
| Companies | Position | End |
|---|---|---|
Sneezz BV
 Sneezz BV Miscellaneous Commercial ServicesCommercial Services Sneezz BVBA helps individuals suffering from allergies such as hay fever by providing information and scientific insight. The private company is based in Borgloon, Belgium. Sneezz was founded in 2017 by Robert Jeroen Dekker, Marleen Johanna Limbourg, Peter Justin Georges Dedrij, Kristof Beenders, and Camiel Dobbelaar, with Robert Jeroen Dekker serving as CEO since 2017. | Founder | 2020-12-31 |
| TIGENIX NV | Corporate Officer/Principal | 2013-12-31 |
| UCB | Corporate Officer/Principal | 2009-12-31 |
Training of Marleen Johanna Limbourg
| Katholieke Universiteit Leuven | Doctorate Degree |
| Vlerick Leuven Gent Management School | Masters Business Admin |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| UCB | Health Technology |
| Private companies | 5 |
|---|---|
TiGenix NV
 TiGenix NV Medical SpecialtiesHealth Technology TiGenix NV engages in the research, development, and commercialization of biopharmaceutical products. The firm's portfolio includes allogeneic adipose-derived stem cells and allogeneic cardiac stem cells. It intends to treat Crohn's disease, sepsis, autoimmune disorders, acute myocardial infarction, and chronic cardiovascular indication. The company was founded by Gil Beyen and Frank P. Luyten on February 21, 2000 and is headquartered in Leuven, Belgium. | Health Technology |
Noshaq SA
Noshaq SA Investment ManagersFinance Noshaq SA is an independent private equity/venture capital firm founded in 1985. Noshaq SA is headquartered in Liege. | Finance |
Bingli NV
Bingli NV Data Processing ServicesTechnology Services Bingli NV is a Belgian healthcare company that aims to free up 30%% of a doctor's time by reducing administrative burden and providing high-quality information for the right care at the right time. The company's mission is to put empathy back in healthcare by asking smart medical questions in advance, allowing doctors to be better prepared and appointments to be more time-efficient. The company is based in Antwerp, Belgium and was founded by Tom Van de Putte, Erica Cornu, Piet Van de Steen. Bingli's algorithms are used by more than 400,000 patients. | Technology Services |
Sneezz BV
Sneezz BV Miscellaneous Commercial ServicesCommercial Services Sneezz BVBA helps individuals suffering from allergies such as hay fever by providing information and scientific insight. The private company is based in Borgloon, Belgium. Sneezz was founded in 2017 by Robert Jeroen Dekker, Marleen Johanna Limbourg, Peter Justin Georges Dedrij, Kristof Beenders, and Camiel Dobbelaar, with Robert Jeroen Dekker serving as CEO since 2017. | Commercial Services |
THERAtRAME SA
THERAtRAME SA BiotechnologyHealth Technology THERAtRAME SA is a drug discovery start-up company based in Liege, Belgium. The Belgian company aims to become a leader in the development and positioning of novel cancer therapies by exploring new target areas to develop innovative cancer therapies. THERAtRAME's discovery platform integrates unique sets of technologies to discover, develop, and position new drugs to beat reluctant cancers. The company exploits the latest scientific discoveries highlighting the unexpected importance of trna epitranscriptomics dynamics in cancer. THERAtRAME is looking for a drug discovery assay developer leader to join their team. The company was founded by Francesca Rapino, Pierre Close, and has a team of experienced professionals with backgrounds in life sciences, medico-marketing, and biotech venture creations. | Health Technology |
- Stock Market
- Insiders
- Marleen Johanna Limbourg
